Stock listing

ADR Stock Price, News, Filings & Events — Adherium Ltd.

Selected listing: ADR · ASX · AUD · AU

This page tracks Adherium Ltd.'s ADR:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ADR:ASX. ADR:ASX is the stock-level entry point for investors researching Adherium Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Adherium Ltd. is a public company listed on the Australian market under the ticker ADR, with a market capitalization of approximately AUD 4.4 million. The company focuses on developing digital health solutions to improve medication adherence for patients with chronic respiratory diseases. Adherium aims to enhance patient outcomes through innovative technology and data-driven insights.

ADR:ASXAUDAUUpdated August 21, 2026
Adherium Ltd. logo
Ticker
ADR:ASX
Asset type
Stock
Market cap
$3.9M
Sector
Health Technology
Industry
Medical Specialties
Exchange
ASX
Currency
AUD

Adherium Ltd. ADR:ASX stock context

This page tracks Adherium Ltd.'s ADR:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ADR:ASX. ADR:ASX is the stock-level entry point for investors researching Adherium Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Adherium Ltd. is a public company listed on the Australian market under the ticker ADR, with a market capitalization of approximately AUD 4.4 million. The company focuses on developing digital health solutions to improve medication adherence for patients with chronic respiratory diseases. Adherium aims to enhance patient outcomes through innovative technology and data-driven insights.

Latest news from Adherium Ltd.

All Adherium Ltd. news →

Research Adherium Ltd.

Alternate listings